Take one tablet daily, following the schedule on the pack
No need for a pill-free week
Not suitable if you no longer have a uterus
Do not use during pregnancy or breastfeeding
Be aware of potential interactions with other medications; always consult the prescribing doctor if in doubt
The package leaflet contains all the information about this product. Read the leaflet before using the product.
For which symptoms is Qlaira used?
Qlaira may also help with:
Do not use Qlaira if you:
Are allergic to estradiol, dienogest, or other ingredients
Are pregnant or breastfeeding
Have an increased risk of blood clots or have previously had thrombosis, pulmonary embolism, heart attack, or stroke
Have a severe liver condition
Have or have had hormone-sensitive cancer (such as breast cancer or endometrial cancer)
Have unexplained vaginal bleeding
Are using other hormonal contraceptives
Are taking medications that may affect Qlaira’s effectiveness (such as treatments for epilepsy, tuberculosis, or HIV – see leaflet)
Possible side effects of Qlaira
Common (in 1 to 10 out of 100 users):
Headache
Abdominal pain
Nausea
Tender or tense breasts
Irregular bleeding
Uncommon (in 1 to 10 out of 1,000 users):
Mood swings
Weight gain
Fatigue
Skin reactions
Rare (in fewer than 1 out of 1,000 users):
Blood clots
Liver problems
High blood pressure
Very rare:
In rare cases, these side effects can lead to serious conditions, such as blood clots in the legs or lungs. Always contact the prescribing doctor immediately in such situations.
For a complete list of side effects, read the leaflet.
Risks of hormone replacement therapy
If you still have a uterus, oestrogen must be combined with progesterone/progestogen, as using oestrogen alone increases the risk of uterine cancer.
The use of medication carries risks, and this also applies to menopausal hormone replacement therapy. For tablets or capsules containing oestrogen and progesterone/progestogen, the following risks apply:
A slightly increased risk of thrombosis, strokes, and gallbladder problems.
Rarely, but an increased risk of breast cancer. This risk appears to increase the longer you use the medication (over 5 years).
Recent studies indicate that menopausal hormone replacement therapy (when started before the age of 60) can have protective effects in addition to its risks. This includes protection against certain types of cancer, osteoporosis, and diabetes.
